FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...